| Document Date: 2014-06-02 15:20:47
Open Document File Size: 910,16 KBShare Result on Facebook
City Rome / / Company GlaxoSmithKline / GE / Almazar AE / Evotec / Therapuetic Inc. / / Continent Europe / / MedicalCondition initial infectious prodrome Conclusions / Esophageal Motility Disorders POEMS / diabetic gastroparesis / vomiting / Gastroparesis / GERD / less severe abdominal pain / disease / Dysphagia / Irritable Bowel Syndrome / nausea / BMI less depression / disorders / / MedicalTreatment incision / antidepressant therapy / relaxation / / Organization Temple University School of Medicine Philadelphia / / Person Peter J. Kahrilas / John E. Pandolfino / Elyse R. Johnston / Henry P. Parkman / Albert J. Bredenoord / André J. Smout Consecutive / / Position Director of GI Motility Laboratory Gastroenterology / Professor of Medicine Director / / Product Granisetron / Lexapro / metoclopramide / /
SocialTag |
What’s Moving in GI Motility & Irritable Bowel Syndrome (IBS) Highlights from DDW 2014 Henry P. Parkman, MD Professor of Medicine